Join the Influenza group to help and get support from people like you.
Influenza News (Page 5)
Related terms: The Flu, Flu
FDA Approves Use of 0.5 mL Dose of Fluzone Quadrivalent (influenza vaccine) in Children as Young as 6 Months of Age
BRIDGEWATER, N.J., Jan. 23, 2019 /PRNewswire/ – The U.S. Food and Drug Administration has approved the use of the 0.5 mL dose of Fluzone Quadrivalent (influenza vaccine) to include children age 6...
FDA Approves Xofluza (baloxavir marboxil) for the Treatment of Acute Uncomplicated Influenza
October 24, 2018 – Today, the U.S. Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older...
Seqirus Receives FDA Approval of Afluria Quadrivalent (Influenza Vaccine) for People Five Years of Age and Older in the U.S.
Cambridge, Mass — September 14, 2017 – Seqirus announced today that the U.S. Food and Drug Administration (FDA) has approved Afluria Quadrivalent (Influenza Vaccine) for use in people five years of a...
GSK Receives FDA Approval for Expanded Indication for FluLaval Quadrivalent (Influenza Vaccine) for Infants 6 Months and Older
18 November 2016 – GSK [LSE/NYSE: GSK] announced today it has received approval from the US Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research expanding the indication ...
Seqirus Receives FDA Approval for Afluria Quadrivalent (Influenza Vaccine) for People 18 Years of Age and Older
CAMBRIDGE, Mass., Aug. 29, 2016 /PRNewswire/ – Seqirus announced today that the US Food and Drug Administration (FDA) has approved Afluria Quadrivalent (Influenza Vaccine) for use in persons 18...
FDA Approves Rapivab (peramivir) to Treat Influenza Infection
December 22, 2014 – On December 19, the U.S. Food and Drug Administration approved Rapivab (peramivir) to treat influenza infection in adults. Influenza, commonly known as the flu, is a contagious...
FDA Approves Flublok - New Seasonal Influenza Vaccine Made Using Novel Technology
January 16, 2013 – The U.S. Food and Drug Administration today announced that it has approved Flublok, the first trivalent influenza vaccine made using an insect virus (baculovirus) expression...
FDA Expands Tamiflu's Use to Treat Children Younger Than One Year
December 21, 2012 – The U.S. Food and Drug Administration today expanded the approved use of Tamiflu (oseltamivir) to treat children as young as 2 weeks old who have shown symptoms of flu for no...
FDA Approves GlaxoSmithKline's Fluarix Quadrivalent - Four-strain Seasonal Influenza Vaccine for Use in the U.S.
LONDON, Dec. 17, 2012 /PRNewswire/ -- GlaxoSmithKline plc [LSE/NYSE: GSK] announced today that the U.S. Food and Drug Administration (FDA) has approved FLUARIX® QUADRIVALENT (Influenza Virus V...
FDA Approves Flucelvax - First Seasonal Influenza Vaccine Manufactured Using Cell Culture Technology
November 20, 2012 – The U.S. Food and Drug Administration announced today the approval of Flucelvax, the first seasonal influenza vaccine licensed in the United States produced using cultured animal...
FDA Medwatch Alert: Tamiflu (oseltamivir phosphate) - Mar 3, 2008
[Posted 03/04/2008] Roche and FDA informed healthcare professionals of neuropsychiatric events associated with the use of Tamiflu, in patients with influenza. These symptoms, as described in post...
FDA Medwatch Alert: Tamiflu (oseltamivir phosphate) - Jan 4, 2007
Indication: Treatment of uncomplicated acute illness due to influenza infection in patients 1 year and older who have been symptomatic for no more than 2 days.[Posted 01/04/2007] Roche notified...
FDA Medwatch Alert: Tamiflu (oseltamivir phosphate) - Nov 13, 2006
[Posted 11/13/2006] Roche and FDA notified healthcare professionals of revisions to the PRECAUTIONS/Neuropsychiatric Events and Patient Information sections of the prescribing information for...
Ask a question
To post your own question to this support group, sign in or create an account.